---
title: Proteometabolomics of initial and recurrent glioblastoma highlights an increased
  immune cell signature with altered lipid metabolism
date: '2023-10-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37882631/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231026180915&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: We describe the potential importance of ASAH1 in tumor
  progression and development of rGBM via metabolic rearrangement and showcase the
  feedback from the tumor microenvironment to plasma proteome profiles. We report
  the potential of ASAH1 and SYNM as plasma markers of rGBM progression. The published
  datasets can be considered as a resource for further functional and biomarker studies
  involving additional -omics ...'
disable_comments: true
---
CONCLUSIONS: We describe the potential importance of ASAH1 in tumor progression and development of rGBM via metabolic rearrangement and showcase the feedback from the tumor microenvironment to plasma proteome profiles. We report the potential of ASAH1 and SYNM as plasma markers of rGBM progression. The published datasets can be considered as a resource for further functional and biomarker studies involving additional -omics ...